Article
12 September 2025 - by Jennifer Carioto, Tracy Margiott
We examine five important ways actuaries can support and add value to the success of life sciences companies.
Article
11 February 2025 - by Tracy Margiott, Samantha D’Anna, Sergey Rubin, Katie McBride
We estimate that proposed frozen formulary legislation could increase payer prescription drug costs by as much as $125 million in 2024 and $270 million in 2028.
Article
10 September 2024 - by Tory Carver, Tracy Margiott, Samantha D’Anna
We share the results of our count of pharmacy services administrative organizations for the Pharmaceutical Care Management Association.
Article
04 June 2024 - by Tory Carver, Samantha D’Anna, Tracy Margiott
We examine the 2021 retail pharmacy reimbursement in Medicare Part D by drug and pharmacy type.
Article
07 March 2023 - by Tory Carver, Samantha D’Anna, Tracy Margiott
Proposed legislation would require PBMs to publish Medicare Part D rebate information, potentially altering the strategies of stakeholders.
Article
07 June 2022 - by Tory Carver, Samantha D’Anna, Tracy Margiott
Insulin products are widely covered on Part D formularies. In this analysis, all beneficiaries enrolled in an individual Medicare Part D plan have coverage in the classes noted, with a range of coverage options by manufacture and drug type.
Article
18 February 2022 - by Tory Carver, Samantha D’Anna, Tracy Margiott
Under Medicare Part D, a proposed rule would require pharmacy DIR to be reflected in the negotiated price used at the point of sale for most drugs.
Video
10 February 2022 - by Courtney R. White, Tracy Margiott, Sara Yi, Greg Sgrosso
What is the new frontier for Part D?
Article
28 January 2022 - by Cody Ball, Deana Bell, Samantha D’Anna, Tracy Margiott, Susan Silseth
A proposed change would require Medicare Part D plans to apply all price concessions they receive from a pharmacy network at the point of sale
Article
25 November 2020 - by Deana Bell, Matthew Hayes, Michelle (Klein) Robb, Tracy Margiott
The two final rules that were released on November 20 will have sweeping impacts to Medicare Part D and Medicare Part B drug pricing.